Present application for patent advocates the U.S. Provisional Patent Application case the 61/694th that on August 29th, 2012 applies for, the U.S. Provisional Patent Application case the 61/731st of application on November 30th, No. 534 1, No. 744 and on January 3rd, 2013 application U.S. Provisional Patent Application case the 61/748th, the priority of No. 667, is incorporated to the reference of quoting as this case at this.
Detailed description of the invention
The invention provides for the controlled conveying of drug substance driving mechanism and adopt the medicine transportation pump of so controlled transport driving.The driving mechanism of this case invention stops utilization with the free axial translation forcing drug substance to send the plunger seal of medicament reservoir by measuring, providing resistance or other mode, to control the speed of drug conveying, and therefore, it is possible to carry out delivering medicament material with variable speed and/or conveying situation.In addition, driving mechanism of the present invention provides integrality deictic function, in order to provide feed back to user before drug conveying, period and afterwards.For example, this user reference feedback can be provided to confirm this system operable and ready for drug conveying.Once start, this system can provide one or more drug conveying state to indicate to user subsequently.When completing drug conveying, this driving mechanism and drug efflux pump can provide dosage to terminate instruction.
In this article use to describe any relative position of parts of this driving mechanism, medicine transportation pump or this case invention, term " axis " (axial) or " axis " the general expression of (axially) is around longitudinal axis " A ", such driving mechanism for preferably to locate, although do not need symmetrically around.Term " radial direction " generally represent that direction is perpendicular to axle A.Term " near-end ", " afterwards ", " backward ", " back of the body " or " dorsad " generally represent in this direction " P " axial direction.Term " far-end ", " front ", " forward direction ", " low district (depressed) " or " forward " generally represent in this direction " D " axial direction.Used in this article, term " glass " be understood to include other similar non-reacted (non-reactive) materials and be suitable for being used in and usually need the pharmaceutical grade of glass to apply, include, but are not limited to some non-reacted polymer such as cyclic olefine copolymer (cyclic olefin copolymers, and cyclic olefin polymer (cyclic olefin polymers, COP) COC).Term " plastic cement " thermoplasticity and thermosetting polymer can be comprised simultaneously.Thermoplastic polymer can soften (re-softened) to its initial condition again by heating; Thermosetting polymer is then not all right.Used in this article, term " plastic cement " the plastic thermoplastic polymer of main expression, for example, such as polyethylene and polypropylene (polyethylene and polypropylene), or acrylic resin (acrylic resin), also typical case comprises other prepare burden such as firming agent, filler, hardening agent, coloring agent and/or plasticiser etc., and can be shaped or molding under heat and pressure.Used in this article, term " plastic cement " do not mean to comprise glass, non-reactive polymer or elastomer, these are applicable to directly contact in the application of medical fluid through accreditation, and wherein this liquid with plastic cement reciprocal action or may may enter into liquid and deteriorated due to substituent group from plastic cement.Term " elastomer ", " elastomeric " or " elastomeric material " the crosslinked thermosetting rubber polymer of main expression, these are than the more easy distortion of plastic cement but be applicable to use together with medical grade fluid through accreditation, and be not easily subject to leaching (leaching) or gas transfer effect under ambient temperature and pressure." fluid " main express liquid, but also can comprise dispersion solid-state suspended substance in a liquid, and the gas be dissolved in wherein or other modes present and comprise the thing together with the liquid in fluid section at this drug efflux pump.According to various pattern described herein and embodiment, refer to " biasing member ", such as within a context one or more is for forcing in the biasing member of plunger seal.Please understand that this biasing member can be any component that can store and release energy.Nonrestrictive example comprises spring, for example such as helical spring, compression or extension spring, torsionspring or leaf spring, resiliency compressible or elastic cord, or any other has the component of similar functions.In at least one embodiment of this case invention, this biasing member is spring, and the best is Compress Spring.
The novel apparatus of this case invention provides the driving mechanism with integrality instruction, and adopts the medicine transportation pump of such driving mechanism.Such equipment safety and be easy to use, and have attractive in appearance for the patient of self-administration (self-administering) and meet the captivation of ergonomics.The function that device described herein combines makes to start, it is simple and easy to operate and lock this device, even if for unbred user.The novel apparatus of this case invention provides function needed for these, without any under the problem about known prior art apparatus.Some nonrestrictive embodiments of the medicine transportation pump of this novelty, driving device and their each assemblies further describe in this article, please refer to institute's accompanying drawings.
Used in this article, term " pump " be mean any amount of, once start can distributing fluids to the delivery system of user.This kind of delivery system comprises, for example, injecting systems, injection pump, bolus syringe and etc.1A-1C figure shows the delivery device of example, according at least one embodiment of this case invention.This delivery device can apply to the conveying of the Drug therapy managing the health entering user.As shown in 1A-1C figure, drug efflux pump 10 comprises pump case 12.Pump case 12 can comprise the shell subassembly of one or more fixed engagement, more easily to manufacture, assemble and to operate this drug efflux pump.For example, drug efflux pump 10 comprises the pump case 12 containing shell 12A and lower casing 12B.This drug efflux pump can comprise actuating mechanism 14, positioning indicator 16 and form 18 further.Form 18 can be any translucent or transmission is surperficial, through the running wherein can watching this drug efflux pump.As shown in Figure 1B, drug efflux pump comprise further assembly platform 20, sterile fluid pipeline 30, have medicament reservoir 50 driving mechanism 100, insert mechanism 200, fluid path connects 300, and power supply and control system 400.One or more parts of such drug efflux pump can turn to their passable forms by module, for example, are individual components and the position be configured at during manufacture on the assembly platform 20 of drug efflux pump 10 before assembling.
Pump case 12 holds all device features and provides the means making device 10 be attached to user skin removedly.Pump case 12 also generator 10 internal part protection affect with Antagonistic Environment.Pump case 12 for meeting body mechanics and design attractive in appearance, not to be trained and/or the user of body damage is easy to packaging, stores, process and use to facilitate on size, shape and correlation function.Further, the outer surface of pump case 12 can be transported and be used to provide Product labelling, safety instruction etc.In addition, as mentioned above, shell 12 can comprise some parts, such as positioning indicator 16 and form 18, and these can provide running to feed back to this user.
In at least one embodiment, drug efflux pump 10 provides actuating mechanism 14 to be moved to trigger initiation command to this power supply and control system 400 by user.In preferred embodiment, this actuating mechanism is start button 14, arranges through pump case 12, such as, by the hole between upper shell 12A and lower casing 12B, and contacts the control arm 40 of this power supply and control system 400.In at least one embodiment, start button 14 can be press button, and in a further embodiment, can be the switch of ON/OFF, trigger or any similar start-up performance known in the art.Pump case 12 also provides positioning indicator 16 and form 18.In a further embodiment, one or more actuating mechanism 14, positioning indicator 16, form 18 can be provided and be combined on shell 12A or lower casing 12B above, for example, such as be placed in when drug efflux pump 10 this user with it time the visible side of this user on.To the details of shell 12 be further described herein, please refer to the miscellaneous part to this case invention and embodiment.
Drug efflux pump is in order to make, once by user by pressing down actuating mechanism to start, this drug efflux pump is initial: insert fluid path and enter this user; Activation, connection or to open between medicament reservoir, fluid path and sterile fluid passage necessary connection; And force and be stored in medicinal fluid in this medicament reservoir by this fluid path and sterile fluid passage for delivering into user.One or more optionally release mechanism can be used, for example, start too early to avoid this drug efflux pump.For example, selectivity body adhering (on-body) sensor 24 (as shown in 1C figure) can be provided as security function to guarantee that this power supply and control system 400 or this actuating mechanism can not be connected, unless the Body contact of drug efflux pump 10 and user in an embodiment.In such an embodiment, body adhering sensor 24 is positioned on the bottom of lower casing 12B, its can from here with the Body contact of this user.Once body adhering sensor 24 displacement, started by press mechanism will be allowed.Therefore, at least one embodiment, body adhering sensor 24 is safety mechanical mechanism, and for example such as mechanical type locking, this prevent by the triggering of actuating mechanism 14 pairs of drug efflux pumps 10.In a further embodiment, this body adhering sensor can be electromechanical sensor, such as, lock sending signal to allow the mechanical type started to power supply and control system 400.In other embodiment another, this body adhering sensor can be based on electronic type, for example such as based on the sensor of electric capacity or resistance, before it must detect and be organized in and allow to start power supply and control system 400.These concepts not mutually exclusive and can use one or more be combined in this case invention width within, for example, to prevent the too early startup of this drug efflux pump.In a preferred embodiment, drug efflux pump 10 uses one or more mechanical type body adhering sensor.Integration release mechanism additionally described herein, please refer to the miscellaneous part to this novel drugs pump.
Power supply and control system:
Power supply and control system 400 comprise power supply, in order to provide the energy to the various electronic units in this drug efflux pump, one or more feedback mechanism, microcontroller, circuit board, one or more conductive spacer and one or more adapter.Also can be included in other electronic units general used in such electronic system, as this area technology personage understand.This one or more feedback mechanism can comprise, for example, and audible alarm such as piezoelectricity alarm and/or visual indicator such as light-emittingdiode (LEDs).For example, this microcontroller can be microprocessor.Power supply and control system 400 control this user and each device interaction and with driving mechanism 100 interface.In an embodiment, power supply and control system 400 and control arm 40 interface are to confirm that when body adhering sensor 24 and/or actuating mechanism 14 are activated.Power supply and control system 400 also can with positioning indicator 16 interface of pump case 12, it may be the transmission-type or translucent material that allow light to transmit, feeds back to this user with what provide vision.Power supply and control system 400 indicate with relay state through one or more adapter and driving mechanism 100 interface, and such as startup, drug conveying and dosage terminate, to this user.This kind of state instruction presents to user by auditory tone, such as, by audible alarm, and or passes through visual detector, such as, by this LEDs.In a preferred embodiment, the control interface between the miscellaneous part of this power supply and control system and this drug efflux pump does not engage or connects, until started by this user.This is required security function in order to be avoided the accidental operation of this drug efflux pump and during additionally can maintaining accommodation can come from storages, to transport etc. in the supply.
Power supply and control system 400 can in order to provide several different positioning indicator to this user.For example, power supply and control system 400 can in order to make after body adhering sensor and/or trigger mechanism are pressed, power supply and control system 400 are provided by positioning indicator 16 " ready to start " status signal, if device start-up check does not propose mistake.Providing this " ready to start " and, in the embodiment of optionally body adhering sensor, if this body adhering sensor maintains the Body contact with this user, power supply and control system 400 will supply power supply to driving mechanism 100 to start the conveying of this Drug therapy, by fluid path connection 300 and sterile fluid passage 30.In a preferred embodiment of the present invention, insertion mechanism 200 and fluid path connect 300 may by user operation start mechanism 14 directly to start.During drug delivery process, power supply and control system 400 are in order to provide dispensing status signal by positioning indicator 16.To be applied at this medicine in the health entering user and after any extra time out terminates, for guaranteeing that all dosage has been transported to this user in fact, power supply and control system 400 provide by positioning indicator 16 " can remove " status signal.This can watch this driving mechanism and drug dose by this user by the form 18 by pump case 12 and carry with individual authentication.In addition, power supply and control system 400 can in order to provide one or more alarm signal by positioning indicator 16, for example alarm of such as indication fault or operation failure situation.
Power supply and control system 400 can additionally in order to receive the various inputs from this user, dynamically to control driving mechanism 100 to meet required rate of drug delivery or situation.For example, power supply and control system 400 can receive input, such as from part or all of startup, pressing and/or release actuating mechanism 14, by power supply and control system 400 with setting, initial, to stop or other modes adjust the control of driving mechanism 100, to meet required rate of drug delivery or situation.Similar, power supply and control system 400 can in order to receive this kind of input to adjust this drug dose volume; To load this driving mechanism, fluid path connects and fluid passage; And/or in order to start, to stop or suspending the running of driving mechanism 100.Can receive this kind of input from the direct action of this user on drug efflux pump 10, such as, from use or the different control interfaces of actuating mechanism 14, or this system 400 can receive this kind of input in order to distally control device.In addition or interchangeable, this kind of input can be pre-programmed.
Other power supply and set-up of control system can use together with novel drugs pump of the present invention.For example, some start delay can be used during drug conveying.As mentioned above, the delay that selectivity is included in this Operation system setting one this kind of is time out, and this is in order to guarantee in fact to carry this whole drug dose before signal completes and delivers to this user.Similar, the startup of this device can require the pressing of the delay of the actuating mechanism 14 of drug efflux pump 10 (that is pressure), before drug efflux pump starts.In addition, this system can comprise and allows this user to respond this dosage end signal and close or the function that stops this drug efflux pump to power.This kind of function can require that the delay of this actuating mechanism presses similarly, closes to avoid the accident of this device.This kind of function provides required security integration and wieldy parameter to give this drug efflux pump.One extra security function can be integrated into pressing that this actuating mechanism divides with preventing portion and, thus cause the part of this drug efflux pump to start.For example, this actuating mechanism and/or power supply and control system in order to make this device not be that thoroughly to close be exactly thoroughly unlatching, can start to avoid part.Such functional description is after this paper in further details, relevant to other patterns of this novel drugs pump.
Fluid path connects:
Several fluid path connection can be used in this case inventive embodiment.Generally speaking, suitable fluid path connection comprises sterile fluid passage, puncture member and sterile sheath and is additional to medicament reservoir or slides and can be integrated in medicament reservoir by puncture seal.This fluid path connects can comprise one or more flow limiter further.Once device 10 normally starts, activation fluid path connects 300 to connect the medicament reservoir of sterile fluid passage 30 to driving mechanism 100.Such connection can be facilitated by puncture member, such as pin, and what penetrate the medicament reservoir of driving mechanism 100 can puncture seal.The aseptic properties of such connection this can be connected in elasticity sterile sheath to maintain by execution.Once start this insertion mechanism, in fact side by side complete this fluid path between medicament reservoir and insertion mechanism, enter in the health of this user to allow drug conveying.
In at least one embodiment of the present invention, this puncture member system that this fluid path connects can puncture seal with what cause the medicament reservoir that penetrates this driving mechanism by the direct action of this user, such as, press this actuating mechanism by user.For example, this actuating mechanism itself can be born this fluid path and connects the translation making this actuating mechanism also cause this fluid path to connect from the translation in its home position.In one suchembodiment, the connection of this fluid path can be similar in fact described in international patent application no PCT/US2012/054861, in quoting it in full in order to all objects herein.According to such embodiment, this connection system presses this actuating mechanism with activation by user, and thus, drive this puncture member can puncture seal by this, because its anti-fluid flows out from this medicament reservoir, until when user needs.In such embodiments, compressible sterile sheath can be attached to regularly between the lid of this medicament reservoir and the connection hinge of this fluid path connection.This puncture member can until need the connection between this fluid connection approach and this medicament reservoir in this sterile sheath.This sterile sheath can be passed through sterilizing to guarantee this puncture member and this fluid path aseptic before being initiated.
Interchangeable, this fluid path connects can be integrated into medicament reservoir for example described in international patent application no PCT/US2013/030478, in quoting it in full in order to all objects herein.According to such embodiment, medicament reservoir can have medicament chamber in bucket between can between puncture seal and plunger seal.Medicinal fluid system is contained in this medicament chamber.Once start this device by user, a driving mechanism applies power and is being contained in the plunger seal in this medicament reservoir.When this plunger seal apply power in this medicinal fluid and any air/gas gap or bubble, combination that is pneumatic and hydraulic pressure is set up in the compression by this air/gas and medicinal fluid, and this power relayed to this slip can puncture seal.Cause this slip to slide towards this lid by puncture seal, cause it by by be retained in this integration sterile fluid approach connect in this puncture member puncture.Therefore, this integration sterile fluid approach connects and is connected (that is this fluid path is opened), be by this air/gas in this medicament chamber manufactured by the startup of driving device and medicinal fluid pneumatic/hydraulic pressure is in conjunction with strength.Connect once this integration sterile fluid approach connects or opened, allow for medicinal fluid from this medicament reservoir, by the connection of this integration sterile fluid approach, sterile fluid passage and the outflow of insertion mechanism, and enter in the health of user for drug conveying.In at least one embodiment, this fluid only flows through the pin of a branch pipe and a sleeve pipe and/or this insertion mechanism, and the aseptic therefore maintaining this fluid path during drug conveying and before.
This fluid path connected mode no matter this drug efflux pump uses, this drug efflux pump can with delivering medicament under different viscosity and volume range.This drug efflux pump can in check flow rate (speed) and/or under designated volume delivering medicament.In an embodiment, this drug delivery process controlled by one or more flow limiter in the connection of this fluid path and/or this sterile fluid passage.In a further embodiment, can by this fluid flow path of change or the geometry of transfer passage, the parts changing this driving mechanism enter with the speed of dispensing this medicine wherein in this medicament reservoir, or above combination, to provide other flow rate.The further details again of 300 and sterile fluid passage 30 is connected, in the paragraph after being provided in hereinafter and with reference to other embodiments about fluid path.
Insert mechanism:
Several insertion mechanism can be applicable in the drug efflux pump of this case invention.The pump-type conveyer device of this case invention can connect fluid flow communication to patient or user, for example, through any suitable hollow pipe.Firm interior vent needle (solid bore needle) can be used with the skin of the patient that punctures and place hollow bushing in be applicable to transfer position, delivering medicament to this patient reach except or regain this firm in vent needle.As mentioned above, can pass through any amount of means and this fluid is introduced in health, include, but are not limited to: automatically insert pin, sleeve pipe, microneedle array (micro-needle array) or inject compound tube.Also several mechanism can be used to enter patient to start the insertion of this pin.For example, biasing member such as spring can be used to provide enough strength to puncture the skin of this patient to cause this pin and sleeve pipe.This identical spring, an extra spring or mechanism similar in addition can be used to regain this pin from this patient.In a preferred embodiment, this general insertion mechanism described by international patent application no PCT/US2012/53174, in quoting it herein in full in order to all objects.This kind of available fortune is set in the skin (or muscle) of this patient of insertion of this drug delivery route or thereunder, in this patient being caused to the mode of minimum pain.Can be used for other methods known of the insertion of fluid path and to be thought and within the category of this case invention.
In at least one embodiment, injecting mechanism 200 comprises the injecting mechanism shell with or more locking form, with a substrate be used for being connected to this assembly platform and/or pump case (as 1B scheme and as shown in 1C figure).This substrate to the connection of this assembly platform 20 can be, for example, makes the bottom of this substrate be allowed through hole in this assembly platform with the health allowing this substrate to direct contact to this user.In such setting, the bottom of this substrate can comprise and can use at drug efflux pump 10 seal dissepiment moving forward and remove.This insertion mechanism can comprise one or more again and insert biasing member, pin, recovery biasing member, sleeve pipe and branch pipe.This branch pipe can be connected to sterile fluid passage 30 and during drug conveying, flow through this branch pipe, sleeve pipe and enter the health of this user to allow fluid.
In used herein; " pin " be mean to represent that various pin includes, but are not limited to known hollow needle; such as rigid hollow draw point (rigid hollow steel needles), and real core pin (solid core needles) is more commonly referred to as " trocar ".In preferred embodiment, this pin is No. 27 real core retainer plate bobbins (27gauge solid core trocar) and in a further embodiment, and the pin that this pin can be any size is suitable for inserting this sleeve pipe for the medicine of desired type and medicament administration (such as subcutaneous, intramuscular, Intradermal etc.).Aseptic startup (sterile boot) can be used in this pin and insert in mechanism.This aseptic startup is foldable sterile film, its fixed engagement in the end of near-end together with this branch pipe and in the end of far-end together with this substrate.In at least one embodiment, this aseptic startup is maintained at the end of fixed engagement at far-end between substrate and insertion mechanism shell.The substrate opening that during substrate is included in the running of this insertion mechanism, this pin and sleeve pipe can be thoroughly logical, as further describing hereinafter.The aseptic system of this sleeve pipe and pin maintains in the sterile part of this insertion mechanism by their original position.In details of the words, as previously discussed, pin and cover piping maintain in the gnotobasis of this branch pipe and aseptic startup.The substrate opening of this substrate also can be closed from ambient non-sterile, such as, by seal dissepiment 254 (as shown in 1C figure) as an example.
According at least one embodiment of this case invention, insertion mechanism is initial is locked as this " ready to use " stage, be by the initial locking contact pin being arranged in the locking form of this insertion mechanism shell.In this initial configuration, insert biasing member and reclaim biasing member each maintain its compression, foment.As shown in Figure 1B, lock contact pin 208 to be directly shifted by user started by press mechanism 14.When this user throws off any release mechanism, such as optionally body adhering sensor 24 (as shown in 1C figure), can started by press mechanism 14 with this drug efflux pump initial.Started by press mechanism 14 directly may cause translation or the displacement of control arm 40, and directly or indirectly causes locking contact pin 208 from its displacement of original position among the locking form 202A inserting mechanism shell 202.The displacement of locking contact pin 208 allow for insertion biasing member and decompresses from its initial compression, foment.The such decompression of this insertion bias mechanism drives this pin and this sleeve pipe to enter to the health of user.When the insertion stage terminates, this recovery biasing member is allowed to expand from its initial actuation state in proximal direction.This pin has been regained in the such expansion of the axis in proximal direction of this recovery biasing member, under the situation that the health simultaneously maintaining this sleeve pipe and this user is communicated with in fluid.Therefore, this insertion mechanism can be used to insert pin and sleeve pipe enters this user, and subsequently, regain this pin maintain simultaneously this sleeve pipe in for drug conveying to the position of this user health.
Driving mechanism:
Refer to the embodiment shown in the 2nd and 3 figure, driving mechanism 100 comprise cover of driver 130 and have the medicament reservoir 50 of lid 52, can puncture seal (not shown), bucket 58 and plunger seal 60.Medicament chamber 21, can between puncture seal and plunger seal 60 between this within this bucket 58, can hold medicinal fluid for the health being conducted through this insertion mechanism and drug efflux pump and entering this user.Sealing described herein can comprise several materials still, in a preferred embodiment, comprises a kind of or more kinds of elastomer or rubber.This driving mechanism can comprise connection bracket 54 again with in the bucket 58 being inserted into medicament reservoir 50 of this puncture member guiding this fluid path to connect.This driving device 100 can hold one or more again and drive biasing member, one or more relieving mechanism and one or more guide rail, described by as further in this paper.The component function of this driving mechanism can puncture seal by this for forcing fluid to be sent from this medicament reservoir, or be preferably the puncture member connected by this fluid path, for being conducted through the connection of this fluid path, sterile fluid passage and inserting the health that mechanism enters to this user.
In a specific embodiment, driving mechanism 100 uses one or more Compress Spring as this biasing member.Once start this drug efflux pump by this user, this power supply and control system can be activated directly or indirectly discharge this Compress Spring from foment.Once release, this Compress Spring can bear antagonism and act on this plunger seal sends this medicament reservoir to force this fluid medicine.This Compress Spring can bear antagonism and act on piston, wherein successively, acts on this plunger seal and sends this medicament reservoir to force this fluid medicine.This fluid path connects that can connect can puncture seal by this, connected by this fluid path to allow fluid to flow from this medicament reservoir at this driving mechanism of startup, sterile fluid passage and insert mechanism, and the health entering user for before drug conveying, while or afterwards.In at least one embodiment, this fluid flows through an only branch pipe and a sleeve pipe of this insertion mechanism, thus the aseptic maintaining this fluid path during drug conveying and before.Such parts and its function hereafter will describe details further.
Refer to now the embodiment of this driving mechanism shown in the 2nd figure and the 3rd figure, this driving mechanism 100 comprise there is lid 52 medicament reservoir 50, can puncture seal (not shown), bucket 58 and plunger seal 60 and optionally connection bracket 54.This medicament reservoir 50 is mounted to the distal tip of cover of driver 130.Drive biasing member 122 and piston 110, be compressed within cover of driver 130, between the proximal end of this medicament reservoir 50 and cover of driver 130, wherein drive biasing member 122 in order to bear the interface surface 110C of piston 110, as herein further described by.Optionally, can use cover sheath 140 between drive the interface surface 110 of biasing member 122 and piston 110 in order to, for example, promote from driving the strength of bias mechanism 122 to piston 110 to be more uniformly distributed, prevent from driving the bending of biasing member 122, and/or hide biasing member from user sight line.The interface surface 110C of piston 110 cause being placed on be adjacent in fact or with the proximal contact of sealing 60.
As shown in Figure 3, piston 110A, 110B can be made up of two parts and be had interface surface 110C to contact this plunger seal.Tether, ribbon, rope (tether, ribbon, string) or other retainer belts (be referred to as herein " tether " 512) can be connected to an end of this piston 110A, 110B.For example, tether 512 can be fixed between two parts of piston 110A, 110B by when assembling to be connected to piston 110A, 110B.Tether 512 is connected to the winch drum 520 of conveying and controlling mechanism 500 at another end.An end of tether 512 is connected to by the use of motor 530, gear assembly and this winch drum 520, and tether 512 is connected to piston 110A, 110B at another end, conveying and controlling mechanism 500 function prevents the free axial translation of piston 110A, 110B for controlling, measuring, provide resistance or other modes, and plunger 60 uses to force drug substance to send medicament reservoir 50.Therefore, conveying and controlling mechanism 500 and driving mechanism 100 (be referred to as herein " controlled transport driving ") overall function is control drug conveying to the speed of this user or situation.
Particularly, the conveying and controlling mechanism 500 of this case invention does not drive the conveying of the flowing material from medicament chamber 21.Caused at piston 110A, 110B and plunger seal 60 from the delivery system of the flowing material of medicament chamber 21 by the dilating effect of biasing member 122 from its initial actuation state.The function of conveying and controlling mechanism 500 is to provide the free action of resistance to piston 110A, 110B and plunger seal 60 on the contrary, when they are promoted from the expansion of its initial actuation state by biasing member 122.Because motor 530 only uses to control, measures, provides resistance or other modes to prevent the free axial translation of this plunger seal, instead of the translation driving this plunger seal, the novel embodiment that less and/or more energy-conservation motor can be invented by this case used.Conveying and controlling mechanism 500, and particularly motor 530, do not drive this conveying but only control this conveying action.The action of the restriction of this tether or otherwise limited piston 110A, 110B and plunger seal 60, but strength is not applied for this conveying.According to preferred embodiment, this controlled transport driving and this case invention drug efflux pump comprise the axial translation that motor 530 is directly or indirectly connected to tether metering piston 110A, 110B and plunger seal 60, its be by biasing member 112 drive with axial translation.Therefore, motor 530 can be selected the electromechanics source of increment action from various, such as there are brush d.c. motor, electronic rectifier motor, stepper motor, electromagnetic coil (brushed DC motors, EC motors, stepper motors, solenoids) or other can produce the technology of controlled action.In at least one embodiment, this motor system the best is stepper motor.
The parts of driving mechanism 100, once start, can be used in the plunger seal 60 of drives medication container 50 in the axial translation of distal direction.Optionally, driving mechanism 100 can comprise one or more compliance function, and this enables the extra axial translation of plunger seal 60, for example, to guarantee that this complete drug dose is transported to this user in fact.For example, plunger seal 60, itself, can have some compressibilityes to allow to promote from the compliance of the medicinal fluid of this medicament reservoir.
This case invention novel controlled transport driving optionally integrated state instruction enter this drug dose carry.By the state reader using one or more state flip-flop and correspondence, the state of this driving mechanism before running, period and this power supply can be relayed to afterwards and control system feeds back to this user to provide.This kind of feedback can be sense of touch, vision and/or audition, as mentioned above, and may be that redundancy makes the feedback of more than one signal or type be provided to this user between the operating period of this device.For example, this user reference feedback can be provided to confirm this system and can operate and ready for drug conveying.Once start, this system can provide one or more drug conveying state to indicate to this user subsequently.When drug conveying completes, this driving mechanism and drug efflux pump can provide dosage to terminate instruction.Since this dosage terminates to indicate system to be tied to the end of this its axial translation of piston arrives, this driving mechanism and drug efflux pump provide certain dosage to terminate instruction to this user.
In at least one embodiment, as shown in the 2nd and the 3rd figure, dosage done state can be provided to indicate to this user once state reader 544 contacts or recognizes be positioned at end-state trigger 512A on tether 512 by the state reader 544 on the end moved axially of contact piston 110A, 110B among the bucket 58 of medicament reservoir 50 and plunger 60.For the sake of clarity, tether 512 can have one or more state flip-flop 512A, such as electronic type contact, optical markings or dynamo-electric contact pin or groove (electrical contacts, optical markings, or electromechanical pins or recesses), these can be contacted by state reader 544 or recognize.For example, state reader 544 can be electronic switch reader to contact the electronic type contact of this correspondence, optical pickup to recognize that the optical markings of this correspondence or machinery or dynamo-electric reader are in order to contact corresponding contact pin, hole or similar pattern on this tether.This state flip-flop 512A can be positioned along tether 512 to be read or to recognize in the beginning of corresponding drug conveying and end and in the position of increment required during drug conveying.Start this drug efflux pump when the release by biasing member 122 and start drug conveying and the strength caused puts on piston 110A, 110B and plunger seal 60, drug conveying to this speed of this user or situation system discharges tether 512 by motor 530, gear assembly and winch drum 520 and allows the axial translation of the expansion of biasing member 122 and piston 110A, 110B and plunger seal 60 to control.When it happens, the state flip-flop 512A of tether 512 contacted by state reader 544 or recognize and before the running of this driving mechanism, period, this state afterwards can be relayed to this power supply and control system feeds back to this user to provide.According to the number of the state flip-flop 512A be positioned on tether 512, the frequency of this increment state instruction can change according to need.As mentioned above, according to the state flip-flop 512A that this system is used, the state reader 544 of certain limit can be used.
In a preferred embodiment, as described herein and consult the 6th figure, state reader 544 can apply tension force to tether 512.Terminate when this system reaches dosage, tether 512 becomes lax and enable state reader 544 and rotates (as shown in Figure 6, a cylindrical protrusion is from this side of state reader 544) around a fulcrum.This rotation can operate electronics or electric mechanical switch, the switch for example in sensor 540, sends the lax signal of tether 512 to power supply and control system 400.In addition, state gear 528 can act as encoder along with sensor 540.This sensor/encoder combines the feedback of system in order to provide motor to rotate, wherein successively recoverable to this position of piston 110 in time not having tether 512 to relax.State reader 544 and sensor/encoder 540 together provide position feedback, dosage end signal and mistake instruction, such as inaccessible, by observe tether 512 relax in arrive by sensor/encoder 540 before the expected numbers object motor that calculates rotates.
Go back to now the embodiment shown in the 2nd and the 3rd figure, the further pattern of this novel driving mechanism will be described and scheme with reference to 4A-4C figure and 5A-5C.4A figure shows the isometric view of this driving mechanism, according at least one the first embodiment, during its initial locked stage.Fluid, such as medicinal fluid, can be contained in bucket 58, between plunger seal 60 and can in the medicament chamber 21 between puncture seal (invisible), for being delivered to user.This puncture seal system can be close to or maintain at least partly in lid 52.Once be started by this user, fluid path connects by being connected to this medicament reservoir by puncture seal 56.As mentioned above, can this puncture member of this fluid path connection of puncture seal can promote that this fluid connects by puncture, and complete from this medicament reservoir, fluid path by the connection of this fluid path, this fluid passage, this insertion mechanism and this sleeve pipe, for the health being delivered to this user of this medicinal fluid.Time initial, one or more locking mechanism (not shown) can maintain the initial actuation position of this biasing member 122 in piston 100A, 110B.Once start this device by this user, this locking mechanism can be removed directly or indirectly to allow the running of this driving mechanism.As shown in 5A figure, piston 110 and biasing member 122 initial time be all in compression, foment in this plunger seal 60 rear.Biasing member 122 can maintain this state until in the startup of this device between the built-in function of crust of the device 130 and the interface surface 110C of piston 110A, 110B.When this locking mechanism is removed or displacement, allow biasing member 122 axially expansion (that is decompression) in this distal direction (that is in direction of this hatched arrows).Such expansion causes biasing member 122 to act on and distally translation interface surface 110C and piston 110, thus distally translation plunger seal 60 to promote the medicament chamber 21 that medicinal fluid sends bucket 58.
As shown in 4B, such distal displacement of piston 110A, 110B and plunger seal 60 continues to force fluid to flow from bucket 58 by sending by puncture seal 56.In at least one embodiment, once state reader 544 contacts or recognizes that state flip-flop 512A is positioned at the position of the corresponding in fact end at piston 110A, 110B of the medicament reservoir 50 of bucket 58 and the axial translation of plunger seal 60 on tether 512, the instruction of dosage done state can be provided to this user.As shown in 4B figure, state flip-flop 512A is positioned along tether 512 in each increment, such as, correspond to the increment of certain volume measured value, indicates to this user to provide increment state.In at least one embodiment, this state reader is the optical states trigger of optical states reader in order to this correspondence of identification on this tether.As this area technology personage understand, this kind of optical states trigger can be by the identifiable labelling of this optical states reader.In other enforcement, this state reader be machinery or dynamo-electric reader in order to corresponding contact pin, hole or the similar aspect of brought into physical contact on this tether.Electronic type contact can be used in similarly as positioning indicator on this tether, and it is contacted by the electronic state reader of this correspondence or otherwise recognized.State flip-flop 512A can be positioned along tether 512 be read or recognize in corresponding drug conveying start and terminate and during drug conveying in the position of required increment.5B figure shows the profile of the viewpoint shown in 4B figure.As shown in the figure, tether 512 in fact axially leads to driving mechanism shell 130, biasing member 122 thoroughly, and contacts to piston 110A, 110B to limit the axial translation of piston 110A, 110B and the plunger seal 60 be positioned near it.
As shown in figure 4 c, conveying and controlling mechanism 500 of the present invention does not drive the conveying of the flowing material from medicament chamber 21.Delivery system from the flowing material of medicament chamber 21 caused in piston 110A, 110B and plunger seal 60 from the dilating effect of its initial actuation state by biasing member 122.The function of conveying and controlling mechanism 500 is to provide resistance moving freely, when they are promoted from the dilating effect of its initial actuation state by biasing member 122 to piston 110A, 110B and plunger seal 60 on the contrary.When motor 530 and conveying and controlling mechanism 500 discharge tether 512, biasing member 122 be allowed to continue from its foment expansion and driven plunger 110A, 110B and plunger seal 60 until plunger seal substantial contact can puncture seal 56.This schemes at 5C can see in this profile provided.In this point, drug substances all in fact be pushed send medicament chamber 21 by fluid path connect 300 for drug conveying to this user.State flip-flop 512A configurable along tether 512 with this position of corresponding piston 110A, 110B, make, when piston 110A, 110B arrive its end moved axially, state flip-flop 512A by state reader 544 read or recognize to provide certain dosage to terminate instruction to this user.As mentioned above, state flip-flop 512A can be positioned along tether 512 be read or recognize in corresponding drug conveying start and terminate and during drug conveying in the position of required increment.This controlled transport driving of this case invention and/or drug efflux pump additionally can be enabled compliance and promote to send medicament chamber 21 to guarantee that drug substances all has in fact been pushed.Plunger seal 60, itself, can have some compressibilityes and promote to allow the compliance from the medicinal fluid of this medicament reservoir.For example, when utilization Pop-up (pop-out) plunger seal, also can from initial state distortion plunger seal, can cause this plunger seal be out of shape or " ejection " to provide the compliance from the medicinal fluid of this medicament reservoir to promote, as shown in 5C figure.Extra or interchangeable, dynamo-electric status switch and coupled components can be used to contact, connect or otherwise enable and transfer to this power supply and control system to send dosage end signal to this user.For example, this status switch can be positioned at for can the far-end of puncture seal 56 and this interconnected near-end be positioned at for plunger seal 60, make once complete in fact the axial translation (and optionally compliance promote) of the plunger seal 60 in bucket 58, this status switch and interconnected coordination transfer to this power supply and control system to send dosage end signal to this user to enable.This arranges to cause further can have certain dosage to terminate instruction to this user.
6th figure shows the perspective view of some parts of controlled transport driving, according at least one embodiment of this case invention.This controlled transport driving adopts the increment positioning indicator mechanism with the state flip-flop of state reader and one or more correspondence.In at least one embodiment, this gear assembly of conveying and controlling mechanism 500 uses the motor 530 with pinion 530A.Pinion 530A contacts the first gear 526A of compound gear 526, and the second gear 526B of compound gear 526 contacts the gear pattern 524B of scroll gear 524.The snail style state 524A contact of scroll gear 524 is connected to the rack barrel 522 of winch drum 520.Tether 512 is wrapped in winch drum 520 at least partly.When motor 530 acts on this gear assembly, this action is passed to winch drum 520 to loosen tether 512 wherein by the interface gear teeth of pinion 530A, compound gear 526, scroll gear 524 and drum-type gear 522.As details above, loosen tether 512 and decrease it and be provided in this resistance on piston 110A, 110B and allow biasing member 122 to expand from its foment, thus actuation plunger sealing 60 is for drug conveying.When tether 512 unties winding from winch drum 520, state reader 544 can read or recognize that increment state indicates before the running of this controlled transport driving the state flip-flop 512A of one or more correspondence on tether 512, period and afterwards to provide.As mentioned above, several state reader can be used in this case inventive embodiment.For example, this driving mechanism shown in 6th figure can use machine performance reader 544, is interposed between on tether 512 with the state instruction change etc. of delivered volume, residual volume, transfer rate or situation (such as) needed for correspondence between this machine performance reader 544 brought into physical contact ridge, hole or other pattern increment ground.When state reader 544 contact by state flip-flop 512A, state reader 544 causes sensor 540 to go to this position of state quantity measurement gear 528 and sends a signal to this power supply and control system for state instruction to this user.As mentioned above, the trigger of the trigger of optical states reader and correspondence, dynamo-electric state reader and correspondence and/or the trigger of machine performance reader and correspondence can all be used by this case inventive embodiment, indicate to this user to provide increment state.
The assembling of controlled transport driving 100, medicine transportation pump 10 or any individual part and/or manufacture, can use several material known in the art and method.For example, several known cleaning solution such as isopropyl alcohol (isopropyl alcohol) and hexane (hexane) can be used to clear up these parts and/or this device.Several known binding agent or glue (adhesives or glues) can be same utilization in the fabrication process.In addition, during known silication (siliconization) and/or lubricating fluid and processing procedure can be used in the parts of this novelty and the manufacture of device.Further, known asepticize processing procedure can apply to one or more this manufacture or assembling stage to guarantee the aseptic of these final products.
This driving mechanism can be assembled in several method.In an assemble method, medicament reservoir 50 can first assembled and load fluid for being delivered to user.Medicament reservoir 50 comprise lid 52, can puncture seal 56, bucket 58 and plunger seal 60.Can puncture seal 56 can fixed engagement between lid 52 and bucket 58, in the distal tip of bucket 58.Bucket 58 by the opening filled drug fluid of proximal end, before inserting plunger seal 60 from the proximal end of bucket 58.Optionally can be mounted to can the distal tip of puncture seal 56 for connection bracket 54.The puncture member that this connection bracket 54 this fluid path bootable connects is inserted in the bucket 58 of medicament reservoir 50.Medicament reservoir 50 can be mounted to the distal tip of cover of driver 130 subsequently.
Drive biasing member 122 can be inserted into the distal tip of cover of driver 130.Optionally, cover sheath 140 and can be inserted into the distal tip of cover of driver 130 to cover in fact biasing member 122.The distal tip that one piston can be inserted into cover of driver 130 with make its be at least partially in biasing member 122 axially thoroughly logical within, and allow the piston interface surface 110C of biasing member 122 contact piston 110A, 110B in the distal tip of biasing member 122.Optionally cover sheath 140 can use with closed biasing member 122 and the piston interface surface 110C of contact piston 110A, 110B.Piston 110A, 110B and driving biasing member 122, and optionally cover sheath 140, can be compressed in cover of driver 130.Such assembly located and drives biasing member 122 in initial compression, foment, and is preferably configured to the proximal end face that piston interface surface 100C contacts the plunger seal 60 in the proximal end of bucket 58.This piston, piston biasing member, contact sheath and optionally parts, can be compressed and lock enter " ready to start " and state in cover of driver 130 in, to add or before installation medicament reservoir 50.Tether 512 is pre-connection to the proximal end of piston 110A, 110B and the thoroughly axial hole of logical biasing member 122 and driving mechanism 130, and is wound around the winch drum 520 being wound around conveying and controlling mechanism 500 by the inside of this drug efflux pump with another end of tether 512 subsequently.
Fluid path connect, and espespecially this fluid path connect sterile sheath, can be connected to this medicament reservoir lid and/or can puncture seal.Fluid passage can be connected to another end that this fluid path connects, wherein this fluid path connection itself is connected to this insertion mechanism to make this fluid path when opening, connecting or other modes are enabled, from this medicament reservoir, fluid path connection, fluid passage, insertion mechanism and directly transmitted the health entering user for drug conveying by this sleeve pipe.Be configured for the parts of the approach of fluid flowing in now assembling.These parts can by several known method asepticize, and subsequently not to be exactly fixedly the shell being assembled in assembly platform or this drug efflux pump removedly, as shown in Figure 1B.
Can expect has some optionally standard package or discrepant driving mechanism 100 or drug efflux pump 10 ought still within the width or scope of this case invention.For example, this embodiment can comprise the utilization of one or more battery to supply this motor, driving mechanism and drug efflux pump that power supply to this case is invented.The cells known of this area certain limit can apply to this object.In addition, upper and lower casing optionally comprises one or more transparent or semitransparent form 18, as shown in 1A figure, causes this user can watch the running of drug efflux pump 10 or confirm whether drug dose completes.Same, drug efflux pump 10 can comprise adhesive patch 26 and paster pad 28 on the bottom end surface of shell 12.Adhesive patch 26 can use to make drug efflux pump 10 be attached to the conveying of health for this drug dose of this user.Technology personage as this area can be gently intelligible, and adhesive patch 26 can have the health that be bonded to this user of adhesive surface for this drug efflux pump.The adhesive surface of adhesive patch 26 can cover by the initial paster pad 28 by non-adhesive, and wherein paster pad 28 removed from adhesive patch 26 before this user health of contact at arrangement drug efflux pump 10.The removing of paster pad 28 can remove the seal dissepiment 254 inserting mechanism 200 again, opens the health of this insertion mechanism to this user for drug conveying (as shown in 1C figure).
Same, one or more parts of controlled transport driving 100 and drug efflux pump 10 can be modified, when functional still within the width or scope of this case invention.For example, as mentioned above, although the shell of drug efflux pump 10 is shown as shell 12A and lower casing 12B two separating component, such parts can be single unified parts.As discussed above, glue, binding agent or other known material or method, can use to make one or more parts of this controlled transport driving and/or drug efflux pump mutually adhere to.Alternative, one or more parts of this controlled transport driving and/or drug efflux pump can be unified parts.For example, on this, shell and lower casing can be weld (screw fit connection by glue or binding agent, screw joint connection, interference engagement, welding, welding, ultrasound, an interference fit, fusion joining, welding, ultrasonic welding) and etc., the separating component be attached together; Or shell and lower casing can be single unified parts on this.This kind of building block and functional aberrancy will be apparent for the technology personage of this area, and therefore, within the width and scope of this case invention.
Please understand from the above description, this controlled transport driving herein and drug efflux pump provide effective percentage and the system of ease of Use for the automatization's drug conveying from medicament reservoir.The embodiment of this novelty described herein provide for the controlled conveying of drug substance driving mechanism and adopt the medicine transportation pump of so controlled transport driving.This speed of drug conveying of this driving mechanism control of this case invention, this is by metering, provides resistance or other modes to stop to apply to force drug substance to send the free axial translation of this plunger seal of medicament reservoir, and therefore, it is possible to delivering medicament material is in variable speed and/or conveying situation.In addition, the driving mechanism of this case invention provide integrality deictic function with provide feed back to this user before drug conveying, period and afterwards.For example, this user reference feedback can be provided to confirm that this system is for can to operate and ready for drug conveying.Once start, this system can provide one or more drug conveying state to indicate to this user subsequently.When drug conveying completes, this driving mechanism and drug efflux pump can provide dosage to terminate instruction.The controlled transport driving of this novelty of this case invention can be started directly or indirectly by this user.Further, this controlled transport driving of this case invention and the novel arrangement of drug efflux pump maintain the aseptic of this fluid path at storage, In transit, and during the running of this device.Because the approach system of this medicinal fluid transmission among this device maintains aseptic condition completely, these parts are only had to need asepticize in the fabrication process.This base part comprises the medicament reservoir of this driving mechanism, this fluid path connects, this sterile fluid passage and this insertion mechanism.In at least one embodiment of this case invention, the miscellaneous part of this power supply and control system, this assembly platform, this control arm, this actuating mechanism, this shell and this drug efflux pump does not need asepticize.This significantly promotes the production capacity of this device and reduces relevant assembly cost.Therefore, when assembling completes, this device of this case invention does not need the asepticize of terminal.
The manufacture of drug efflux pump comprises both this controlled transport driving additional and medicament reservoir, discretely or as one of both bonded blocks, to assembly platform or the step of the shell of this drug efflux pump.The method of this manufacture comprises this fluid path additional connection, medicament reservoir again and inserts mechanism to this assembly platform or shell.The parts that this drug efflux pump is other, as mentioned above, comprise this power supply and control system, this actuating mechanism and this control arm can add, to perform or pre-assembled to this assembly platform or shell.Adhesive patch and paster pad can be attached to the case surface of this drug efflux pump contacting user during the running of this device.
The method operating this drug efflux pump comprises the following steps: start this actuating mechanism by user; Bit andits control arm inserts mechanism to start; And start power supply and control system flows through this drug efflux pump to start controlled transport driving with drive fluid medicine, according to speed or the situation of controlled drug conveying.The method can comprise the following steps again: engage optionally body adhering sensor in startup this actuating mechanism before.Same the method can comprise the following steps again: set up and be connected to connection between medicament reservoir between fluid path.Further, the method of this running can comprise the plunger seal of translation in this controlled transport driving, the piston of dilating effect in medicament reservoir by this biasing member flows through this medicament reservoir, the connection of this fluid path, sterile fluid passage and this insertion mechanism for the health being delivered to user of this fluid medicine to force fluid medicine, and tether wherein can be used to limit the free axial translation of this piston.The method of the running of this insertion mechanism and this drug efflux pump can obtain better understanding with reference to 4A-4C figure and 5A-5C figure, as mentioned above.
Present disclosure entire chapter, object is to describe preferred embodiment of the present invention under the specific collection not limiting the invention to any one embodiment or function.Various conversion and amendment can be carried out for described embodiment and graphic, not departing under this case invention.Originally each patent mentioned in this description and scientific and technological file, computer program and algorithm is exposed in, by quoting its entirety to be incorporated to herein.